We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




AI Algorithm with Single-Lead EKG Predicts Long-Term Patient Survival After Cardiac Surgery

By HospiMedica International staff writers
Posted on 10 Dec 2021

A novel artificial intelligence (AI) algorithm that identifies a cardiac dysfunction from a single-lead EKG also can predict long-term patient survival after cardiac surgery, according to new research. More...

The study by researchers at the Mayo Clinic (Rochester, MN, USA) found that an algorithm that previously has shown it can detect patients with reduced left ventricular ejection fraction also may predict long-term mortality after cardiac surgery, making it a potentially valuable tool for assessing risk as patients and their health care providers consider surgery.

The retrospective study involved reviews of 20,627 patients at Mayo Clinic from 1993 to 2019. The patients underwent coronary artery bypass grafting, valve surgery or both, and they had a left ventricular ejection fraction of more than 35%. Of these patients, 17,125 had a normal AI EKG screen and 3,502 had an abnormal screen. Patients with an abnormal screen tended to be older with more comorbidities.

The algorithm was applied to the most recent EKG the patients had within 30 days before surgery. Baseline characteristics, as well as in-hospital, 30-day and long-term mortality data, were extracted from the Mayo Clinic cardiac surgery database. Probability of survival at five years was 86.2% for patients with a normal screen versus 71.4% for those with an abnormal screen. The 10-year probability of survival was 68.2% and 45.1%, respectively, for the two groups.

The study is believed to be the first large-scale research to explore the usefulness of AI algorithms with a single EKG to better predict cardiac surgery outcomes. Because the algorithm uses a routine and relatively inexpensive test, it could be applied widely after validation. Additional studies are underway to determine whether the information provided by the algorithms can improve diagnosis, decision-making and clinical outcomes. The use of AI-based tests in cardiology is becoming more common in academic health care centers, and the results of this study may encourage more providers to consider their clinical significance.

"Our study finds there is a clear correlation between long-term mortality and a positive AI ECG screen for reduced ejection fraction among patients without apparent severe cardiomyopathy," says Mohamad Alkhouli, M.D., a Mayo Clinic cardiologist and the study's senior author. "This correlation was consistent among patients undergoing valve, coronary bypass, or valve and coronary bypass surgery."

"Our study documented the algorithm's prognostic value in predicting long-term, all-cause mortality after cardiac surgery," added Dr. Alkhouli. "The analysis showed that an abnormal AI screen was associated with a 30% increase in long-term mortality after valve or coronary bypass surgery. For clinicians, this may aid in risk stratification of patients referred for surgery and facilitate shared decision-making."

Related Links:
Mayo Clinic 


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Ultrasound Needle Guidance System
SonoSite L25
New
Electric Bed
DIXION Intensive Care Bed
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The skin-like sensor monitors internal and external body movement, and electrical signals (Photo courtesy of Huanyu “Larry” Cheng and Jennifer M. McCann)

Skin-Like Sensor Monitors Vital Signs and Tracks Healing After Surgery

Medical conditions such as bladder control issues and the need for monitoring vital signs after surgery require precise, long-term tracking to improve patient outcomes. These conditions can be challenging... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: A research collaboration aims to further advance findings in human genomics research in cardiovascular diseases (Photo courtesy of 123RF)

Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies

A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.